Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax

Myelodysplastic syndromes are characterized by ineffective hematopoiesis in one or more lineages of the bone marrow. They are a group of heterogeneous clonal stem cell malignancies with a high risk to progress to acute myeloid leukemia. Currently, there are no curative FDA-approved medications for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Jehangir, Waqas, Karabachev, Alexander, Jahangir, Taimoor, Umyarova, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091525/
https://www.ncbi.nlm.nih.gov/pubmed/32231817
http://dx.doi.org/10.1155/2020/9031067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091525/
https://www.ncbi.nlm.nih.gov/pubmed/32231817
http://dx.doi.org/10.1155/2020/9031067

Ejemplares similares